Key Metrics
CiteScore 

3.7
H-Index 

44
Impact Factor 

< 5
SJR 

Q1Rheumatology

SNIP 

1.17
Recommended pre-submission checks
Powered by 

Topics Covered on Therapeutic Advances in Musculoskeletal Disease
Therapeutic Advances in Musculoskeletal Disease Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Musculoskeletal Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Therapeutic Advances in Musculoskeletal Disease
Early identification of difficult-to-manage axial spondyloarthritis using machine-learning decision trees
- 16 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Patients with poorer health status are more likely to have difficult-to-manage axial spondyloarthritis: insights from a real-world cohort
- 14 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Development and validation of a clinical scoring system for the prediction of methotrexate treatment response in rheumatoid arthritis patients: a multicenter real-world study
- 10 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Towards an individualised approach to pain management in inflammatory arthritis
- 9 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Mapping emotional function in fibromyalgia: integrating alexithymia, pain catastrophizing, and self-compassion
- 1 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate
- 28 May 2026
- Therapeutic Advances in Musculoskeletal Disease
Early identification of difficult-to-manage axial spondyloarthritis using machine-learning decision trees
- 16 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Patients with poorer health status are more likely to have difficult-to-manage axial spondyloarthritis: insights from a real-world cohort
- 14 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Development and validation of a clinical scoring system for the prediction of methotrexate treatment response in rheumatoid arthritis patients: a multicenter real-world study
- 10 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Towards an individualised approach to pain management in inflammatory arthritis
- 9 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Mapping emotional function in fibromyalgia: integrating alexithymia, pain catastrophizing, and self-compassion
- 1 Jun 2026
- Therapeutic Advances in Musculoskeletal Disease
Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate
- 28 May 2026
- Therapeutic Advances in Musculoskeletal Disease